Long-Term Efficacy and Safety of Ipragliflozin plus Insulin in Japanese Patients with Type 2 Diabetes (IOLITE)

被引：0
|
作者：
Ishihara, Hisamitsu
Yamaguchi, Susumu
Nakao, Ikko
Okitsu, Akira
Asahina, Seitaro
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1250-P
引用
收藏
页码：A335 / A335
页数：1
相关论文
共 50 条
  • [31] Long-Term Efficacy and Safety of Saxagliptin in a Triple-Therapy Regimen With Insulin and Metformin for Type 2 Diabetes
    Charbonnel, Bernard
    Barnett, Anthony H.
    Monyak, John
    Minervini, Gianmaria
    Iqbal, Nayyar
    DIABETES, 2012, 61 : A292 - A292
  • [32] Long-term efficacy and safety of vildagliptin add-on therapy in type 2 diabetes mellitus with insulin treatment
    Kanazawa, Ippei
    Tanaka, Ken-ichiro
    Notsu, Masakazu
    Tanaka, Sayuri
    Kiyohara, Nobuaki
    Koike, Sayo
    Yamane, Yuko
    Tada, Yuko
    Sasaki, Motofumi
    Yamauchi, Mika
    Sugimoto, Toshitsugu
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 123 : 9 - 17
  • [33] Long-term efficacy of the sodium-glucose cotransporter 2 inhibitor, ipragliflozin, in a case of type A insulin resistance syndrome
    Nagashima, Shuichi
    Wakabayashi, Tetsuji
    Saito, Naoko
    Takahashi, Manabu
    Okada, Kenta
    Ebihara, Ken
    Ishibashi, Shun
    JOURNAL OF DIABETES INVESTIGATION, 2020, 11 (05) : 1363 - 1365
  • [34] Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM
    Nakamura, Ichiro
    Maegawa, Hiroshi
    Tobe, Kazuyuki
    Uno, Satoshi
    DIABETES THERAPY, 2021, 12 (05) : 1359 - 1378
  • [35] Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM
    Ichiro Nakamura
    Hiroshi Maegawa
    Kazuyuki Tobe
    Satoshi Uno
    Diabetes Therapy, 2021, 12 : 1359 - 1378
  • [36] Long-term Efficacy and Safety of Linagliptin in Type 2 Diabetes Patients with Moderate to Severe Renal Disease
    Groop, Per-Henrik
    Perkovic, Vlado
    Cooper, Mark
    Crowe, Susanne
    Lee, Jisoo
    Patel, Sanjay
    Von Eynatten, Maximilian
    DIABETES, 2014, 63 : A264 - A264
  • [37] Efficacy and safety of long-term insulin pump treatment in patients with type 1 diabetes aged over 50 years
    Matejko, Bartlomiej
    Krzyzowska, Sabina
    Kiec-Wilk, Beata
    Malecki, Maciej Tadeusz
    Klupa, Tomasz
    ENDOCRINE JOURNAL, 2020, 67 (03) : 367 - 371
  • [38] EFFICACY AND SAFETY OF LONG-TERM INSULIN PUMP TREATMENT IN PATIENTS WITH TYPE 1 DIABETES AGED OVER 50 YEARS
    Matejko, B.
    Krzyzowska, S.
    Kiec-Wilk, B.
    Malecki, M.
    Klupa, T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A172 - A173
  • [39] Long-term Efficacy and Safety of Luseogliflozin, an SGLT2 inhibitor, in Elderly Patients with Type 2 Diabetes
    Sasaki, Takashi
    Seino, Yutaka
    Haneda, Masakazu
    Inagaki, Nobuya
    Fukatsu, Atsushi
    Ubukata, Michito
    Sakai, Soichi
    Samukawa, Yoshishige
    DIABETES, 2014, 63 : A275 - A275
  • [40] A randomized, double-blind, placebo-controlled study on long-term efficacy and safety of ipragliflozin treatment in patients with type 2 diabetes mellitus and renal impairment: results of the Long-Term ASP1941 Safety Evaluation in Patients with Type 2 Diabetes with Renal Impairment (LANTERN) study
    Kashiwagi, A.
    Takahashi, H.
    Ishikawa, H.
    Yoshida, S.
    Kazuta, K.
    Utsuno, A.
    Ueyama, E.
    DIABETES OBESITY & METABOLISM, 2015, 17 (02): : 152 - 160
12345